Metronomic Chemotherapy with Vinblastine, Cyclophosphamide, Methotrexate and Celecoxib in Progressive or Relapsed Childhood Cancers

被引：0
|
作者：
Aydin, B. [1 ]
Akyuz, C. [1 ]
Kalkan, N. [1 ]
Kurucu, N. [1 ]
Yalcin, B. [1 ]
Varan, A. [1 ]
Kutluk, T. [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Paediat Oncol, Ankara, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-0482
引用
收藏
页码：S193 / S193
页数：1
相关论文
共 50 条
  • [41] High-dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma
    Buckstein, Rena
    Kerbel, Robert S.
    Shaked, Yuval
    Nayar, Rakesh
    Foden, Cindy
    Turner, Ruth
    Lee, Christine R.
    Taylor, Diane
    Zhang, Liying
    Man, Shan
    Baruchel, Sylvain
    Stempak, Diana
    Bertolini, Francesco
    Crump, Michael
    CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5190 - 5198
  • [42] Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling
    Takata, R
    Katagiri, T
    Kanehira, M
    Tsunoda, T
    Shuin, T
    Miki, T
    Namiki, M
    Kohri, K
    Matsushita, Y
    Fujioka, T
    Nakamura, Y
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2625 - 2636
  • [43] VEGF/SVEGFR-2 and VEGF/TSP-1 ratios as probable predictors of response to metronomic chemotherapy with Cyclophosphamide and Celecoxib in advanced breast cancer patients.
    Perroud, Herman A.
    Alasino, Carlos M.
    Rico, Maria J.
    Queralt, Francisco
    Pezzotto, Stella M.
    Rozados, Viviana R.
    Graciela Scharovsky, O.
    CANCER RESEARCH, 2013, 73 (08)
  • [44] Low dose metronomic cyclophosphamide, methotrexate (LDCM) and aspirin for patients with residual disease after neoadjuvant chemotherapy for stage II-III breast cancer.
    Ninfea, Jose Ignacio Ruades
    Burdette-Radoux, Susan
    Melissa of Sands
    Rincon, Mercedes
    Levist, Jamie E.
    Holmes, Chris E.
    Wood, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
    Perroud, H. A.
    Rico, M. J.
    Alasino, C. M.
    Pezzotto, S. M.
    Rozados, V. R.
    Scharovsky, O. G.
    INDIAN JOURNAL OF CANCER, 2013, 50 (02) : 115 - 121
  • [46] EFFECTIVE NEW LOW TOXICITY CHEMOTHERAPY WITH CARBOPLATIN, VINBLASTINE AND METHOTREXATE FOR SMALL-CELL LUNG-CANCER - A RANDOMIZED TRIAL AGAINST DOXORUBICIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE
    JONES, AL
    HOLBORN, J
    ASHLEY, S
    SMITH, IE
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (07) : 866 - 870
  • [47] Combined chemotherapy with fludarabine, cyclophosphamide and rituximab (FCR) for relapsed or untreated progressive chronic lymphocytic leukemia (CLL). A single center experience.
    Pavlovsky, S
    Pavlovsky, C
    Pardo, L
    Sapia, S
    Fernandez, II
    Juni, M
    BLOOD, 2005, 106 (11) : 340B - 340B
  • [48] EFFICACY AND TOLERABILITY OF METRONOMIC CHEMOTHERAPY (mChT) WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND CAPECITABINE (CMX) IN PATIENTS WITH HEAVILY PRETREATED ADVANCED BREAST CANCER. RESULTS FROM A MULTICENTER RETROSPECTIVE STUDY
    Saavedra, Cristina
    Gion, Maria
    Cortes, Alfonso
    Cortez, Patricia
    Garrigos, Laia
    Perez-Garcia, Jose Manuel
    Antonarelli, Gabriele
    Cortes, Javier
    CANCER RESEARCH, 2024, 84 (09)
  • [49] PHASE-II CHEMOTHERAPY TRIAL FOR BRONCHOPULMONARY CANCERS (EXCEPTING SMALL-CELL), USING CISPLATINUM-BLEOMYCIN-VINBLASTINE-FLUOROURACIL-METHOTREXATE-FOLINIC-ACID
    MARECHAL, F
    INCATASCIATO, C
    CATTAN, A
    BULLETIN DU CANCER, 1987, 74 (06) : 701 - 701
  • [50] SEQUENTIAL CONTINUOUS INFUSION WITH DOXORUBICIN AND VINBLASTINE - AN EFFECTIVE CHEMOTHERAPY COMBINATION FOR PATIENTS WITH ADVANCED BREAST-CANCER PREVIOUSLY TREATED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FU, VINCRISTINE, AND PREDNISONE
    TANNIR, N
    YAP, HY
    HORTOBAGYI, GH
    HUG, V
    BUZDAR, AU
    BLUMENSCHEIN, GR
    CANCER TREATMENT REPORTS, 1984, 68 (7-8): : 1039 - 1041
12345